ATE231522T1 - Fragmente eines oberflächenaktiven lungenproteins - Google Patents

Fragmente eines oberflächenaktiven lungenproteins

Info

Publication number
ATE231522T1
ATE231522T1 AT93905865T AT93905865T ATE231522T1 AT E231522 T1 ATE231522 T1 AT E231522T1 AT 93905865 T AT93905865 T AT 93905865T AT 93905865 T AT93905865 T AT 93905865T AT E231522 T1 ATE231522 T1 AT E231522T1
Authority
AT
Austria
Prior art keywords
fragments
lung protein
active lung
protein
active
Prior art date
Application number
AT93905865T
Other languages
German (de)
English (en)
Inventor
Madhup Krishna Dhaon
Edwin Orville Lundell
Virender Kumar Sarin
Constance Hope Baxter
Darryl Robin Absolom
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE231522T1 publication Critical patent/ATE231522T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT93905865T 1992-04-10 1993-02-09 Fragmente eines oberflächenaktiven lungenproteins ATE231522T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86691692A 1992-04-10 1992-04-10
PCT/US1993/001197 WO1993021221A1 (en) 1992-04-10 1993-02-09 Pulmonary surfactant protein fragments

Publications (1)

Publication Number Publication Date
ATE231522T1 true ATE231522T1 (de) 2003-02-15

Family

ID=25348718

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905865T ATE231522T1 (de) 1992-04-10 1993-02-09 Fragmente eines oberflächenaktiven lungenproteins

Country Status (8)

Country Link
US (2) US5547937A (enExample)
EP (1) EP0635028B1 (enExample)
AT (1) ATE231522T1 (enExample)
AU (1) AU3662593A (enExample)
DE (1) DE69332654T2 (enExample)
ES (1) ES2192190T3 (enExample)
TW (1) TW240170B (enExample)
WO (1) WO1993021221A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020307A (en) * 1997-04-25 2000-02-01 Ony, Inc. Compositions and methods for isolating lung surfactant hydrophobic proteins SP-B and SP-C
US6013764A (en) 1996-07-17 2000-01-11 Ortho Pharmaceutical Corp. Liquid phase peptide synthesis of KL-4 pulmonary surfactant
US5958902A (en) 1997-04-16 1999-09-28 Wisconsin Alumni Research Foundation Method and composition for treating sleep apnea
WO2001039573A2 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von lungensurfactant zur behandlung von legionärskrankheit
US6660833B1 (en) * 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
ATE538814T1 (de) 2005-01-06 2012-01-15 Discovery Lab Inc Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien
CA2606688A1 (en) * 2005-05-03 2006-11-09 Ross Allen Ridsdale Phospholipid formulations and uses thereof in lung disease detection and treatment
PT103484B (pt) * 2006-05-19 2008-03-31 Univ Do Minho Formulação com domínios de ligação hidrófobos e domínios de ligação a hidratos de carbono para aplicações cosméticas nomeadamente para tratamento de fibras queratinosas como o cabelo.
CA2663795A1 (en) * 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
CA2690089A1 (en) * 2007-06-05 2008-12-11 Paka Pulmonary Pharmaceuticals, Inc. Lung surfactant drug conjugates and uses thereof
CN102271666A (zh) 2008-12-10 2011-12-07 Paka肺部医药公司 用于向肺脏递送药物的方法和组合物
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234475A (en) * 1975-08-15 1980-11-18 The Gillette Company Reacting protein with organic acid
US5055553A (en) * 1985-09-26 1991-10-08 Genetics Institute Inc. Low molecular weight pulmonary surfactant proteins
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
EP0458167B1 (en) * 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
JP3442075B2 (ja) * 1991-05-23 2003-09-02 メレルファーマス−テイカルズ インコーポレイテッド 結合組織分解を防止するためのカテプシンｇとエラスターゼの阻害剤

Also Published As

Publication number Publication date
EP0635028A4 (en) 1995-11-22
DE69332654T2 (de) 2003-09-25
AU3662593A (en) 1993-11-18
US5753621A (en) 1998-05-19
EP0635028A1 (en) 1995-01-25
US5547937A (en) 1996-08-20
DE69332654D1 (de) 2003-02-27
EP0635028B1 (en) 2003-01-22
WO1993021221A1 (en) 1993-10-28
ES2192190T3 (es) 2003-10-01
TW240170B (enExample) 1995-02-11

Similar Documents

Publication Publication Date Title
ATE231522T1 (de) Fragmente eines oberflächenaktiven lungenproteins
BG105764A (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
FI881720A0 (fi) Desinficeringskompositioner och deras foerfaranden.
ATE152172T1 (de) Herstellung eines rekombinanten menschlichen interleukin-1-hemmers
TR200200068T2 (tr) Nematisital triflüorobütenler
DE69202207D1 (de) Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan.
DE3853646D1 (de) Breitbandantimikrobium für Reiniger für harte Oberflächen.
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
DE69100792D1 (de) Aerosolträger.
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
IT8419729A0 (it) Procedimento per la preparazione di vaccini polivalenti adsorbiti liofilizzati.
WO1992012715A3 (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
DE69113848D1 (de) Verwendung von Phosphatidylglycerol(diC 18:10) zur Behandlung obstruktiver Atemwegserkrankungen.
PL335134A1 (en) Novel pharmaceutic compositions useful in treating ards and trds
ES2122015T3 (es) Uso de urodilatina en enfermedades pulmonares y bronquiales.
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
DK0551077T3 (da) Anvendelse af humant atrialt natriuretisk peptid til fremstilling af farmaceutiske præparater til behandling af akut lungeb
PT87796A (pt) Process for the preparation of biocide compounds for the treatment of air in systems of air-conditioned
DK0535387T3 (da) Echogene partikler, fremgangsmåde til deres fremstilling og deres anvendelse
CA2218561A1 (en) Compounds and methods of use to treat infectious diseases
NZ275318A (en) 5,6-dihydro-4-substitutedpyran-2-one and -pyrid-2-one derivatives and the corresponding cyclohex-2-enone analogues
ID28119A (id) Pati yang dimodifikasi stabil-garam
EP0325768A3 (en) Non-reverting rna viruses
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
EP0374089A3 (en) Use of somatostatin derivatives as lung protecting agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0635028

Country of ref document: EP

REN Ceased due to non-payment of the annual fee